Samsung BioLogics Co Ltd

XKRX:207940 (Korea (the Republic of))  
â‚© 760000.00 (+0.93%) Jun 5
60.43
P/B:
5.41
Market Cap:
â‚© 54.09T ($ 39.54B)
Enterprise V:
â‚© 53.74T ($ 39.29B)
Volume:
64.53K
Avg Vol (2M):
54.24K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Samsung BioLogics Co Ltd ( XKRX:207940 ) from 2016 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Samsung BioLogics stock (XKRX:207940) PE ratio as of Jun 06 2024 is 60.43. More Details

Samsung BioLogics Co Ltd (XKRX:207940) PE Ratio (TTM) Chart

To

Samsung BioLogics Co Ltd (XKRX:207940) PE Ratio (TTM) Historical Data

Total 1278
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Samsung BioLogics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 60.4 2024-03-29 66.1
2024-06-05 60.4 2024-03-28 66.2
2024-06-04 59.9 2024-03-27 69.4
2024-06-03 59.8 2024-03-26 68.7
2024-05-31 58.0 2024-03-25 69.7
2024-05-30 58.2 2024-03-22 69.7
2024-05-29 57.8 2024-03-21 71.1
2024-05-28 59.2 2024-03-20 70.5
2024-05-27 60.0 2024-03-19 70.4
2024-05-24 59.7 2024-03-18 71.3
2024-05-23 61.2 2024-03-15 68.5
2024-05-22 61.8 2024-03-14 69.7
2024-05-21 61.9 2024-03-13 68.7
2024-05-20 62.8 2024-03-12 69.7
2024-05-17 62.6 2024-03-11 68.9
2024-05-16 62.3 2024-03-08 69.5
2024-05-14 62.1 2024-03-07 66.1
2024-05-13 62.1 2024-03-06 65.2
2024-05-10 62.6 2024-03-05 64.7
2024-05-09 62.1 2024-03-04 64.2
2024-05-08 62.9 2024-02-29 64.2
2024-05-07 62.4 2024-02-28 66.5
2024-05-03 61.3 2024-02-27 67.0
2024-05-02 61.6 2024-02-26 67.2
2024-04-30 62.1 2024-02-23 67.5
2024-04-29 61.6 2024-02-22 68.0
2024-04-26 61.2 2024-02-21 68.3
2024-04-25 62.0 2024-02-20 67.9
2024-04-24 62.8 2024-02-19 68.1
2024-04-23 62.9 2024-02-16 68.7
2024-04-22 63.8 2024-02-15 67.9
2024-04-19 62.1 2024-02-14 68.7
2024-04-18 62.8 2024-02-13 69.5
2024-04-17 61.7 2024-02-08 67.6
2024-04-16 62.4 2024-02-07 68.5
2024-04-15 63.0 2024-02-06 70.2
2024-04-12 62.8 2024-02-05 70.3
2024-04-11 63.2 2024-02-02 71.3
2024-04-09 64.0 2024-02-01 68.8
2024-04-08 64.8 2024-01-31 69.7
2024-04-05 64.6 2024-01-30 68.3
2024-04-04 65.0 2024-01-29 66.4
2024-04-03 64.6 2024-01-26 64.2
2024-04-02 64.9 2024-01-25 65.2
2024-04-01 64.9 2024-01-24 65.4

Samsung BioLogics Co Ltd (XKRX:207940) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.